Cargando…
Beyond Single-Cell Analysis of Metallodrugs by ICP-MS: Targeting Cellular Substructures
Platinum compounds such as cisplatin (cisPt) embody the backbone of combination chemotherapy protocols against advanced lung cancer. However, their efficacy is primarily limited by inherent or acquired platinum resistance, the origin of which has not been fully elucidated yet, although of paramount...
Autores principales: | Galé, Audrey, Hofmann, Lukas, Lüdi, Nicola, Hungerbühler, Martin Nils, Kempf, Christoph, Heverhagen, Johannes Thomas, von Tengg-Kobligk, Hendrik, Broekmann, Peter, Ruprecht, Nico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431512/ https://www.ncbi.nlm.nih.gov/pubmed/34502377 http://dx.doi.org/10.3390/ijms22179468 |
Ejemplares similares
-
Generation of Stable cisPt Resistant Lung Adenocarcinoma Cells
por: Ruprecht, Nico, et al.
Publicado: (2020) -
(1)H HR-MAS NMR Based Metabolic Profiling of Lung Cancer Cells with Induced and De-Induced Cisplatin Resistance to Reveal Metabolic Resistance Adaptations
por: Vermathen, Martina, et al.
Publicado: (2021) -
Combination of ICP-MS, capillary electrophoresis, and their hyphenation for probing Ru(III) metallodrug–DNA interactions
por: Foteeva, Lidia S., et al.
Publicado: (2017) -
Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents?
por: Mosler, Frank, et al.
Publicado: (2021) -
Fluidodinâmica Computacional (CFD) para Prever Alterações Patológicas na Aorta: Está Pronta para Uso Clínico?
por: Obrist, Dominik, et al.
Publicado: (2022)